Purpose
To develop a genetically-attenuated vaccine for malaria elimination. To provide cryopreserved sporozoites as a challenge parasite and to adapt P. falciparum to Anopheles gambiae mosquitoes for human challenge trials.
Grantee
Division
Global Health
Date
OCTOBER 2025
Region served
AFRICA
Committed amount
$4,938,027
Grant topic
Malaria
Duration (months)
48
Grantee location
Seattle, Washington, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.